论文信息 - Cardiovascular risk factors influence response to biological therapies in psoriasis. - 字舞流文

Cardiovascular risk factors influence response to biological therapies in psoriasis.

E. Coto | R. Queiro-Silva | P. Coto-Segura | A. Batalla | T. Abalde | L. González-Lara | D. González-Fernández | L. Salgado‐Boquete

[1] Z. Adamski,et al. Factors affecting response to biologic treatment in psoriasis , 2014, Dermatologic therapy.

[2] E. Coto,et al. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta‐analysis , 2013, The British journal of dermatology.

[3] P. Coto-Segura,et al. Psoriasis and hypertension: a case‐control study , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4] James T. Elder,et al. TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis , 2011, The Journal of investigative dermatology.

[5] F. Aubin,et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.